Back to home pageNOVEMBER 1992 - SERIES K (IMPLANTS AND INJECTABLE), NUMBER 4
Decisions for Norplant Programs
Norplant is new. After decades of careful development and testing, Norplant implants are taking their place as the newest choice among family planning methods. Family planning programs now face important decisions about whether to offer Norplant and how to offer it in ways that meet clients' needs. (NORPLANT, PROGRAMME DE PLANNING FAMILIAL)
JUNE 1993 - SERIES L (WORLD POPULATION PROBLEMS), NUMBER 9)
Controlling Sexually Transmitted Diseases
While AIDS seizes the headlines, other sexually transmitted diseases (STDs) create devastation of their own. In women STDs can lead to pelvic inflammatory disease, causing lifelong pain, infertility, and extopic pregnancy, which can kill. Children are born with blinding eye infections. Men are left infertile. People die of advanced stages of syphilis. Furthermore, STDs multiply the transmissibility of HIV, the AIDS virus, as much as ninefold. (SEXUALLY TRANSMITTED DISEASES, AIDS)
1994 - SERIE M (PROGRAMMES DE PLANNING FAMILIAL), NUMBER 12
Opportunities for Women Through Reproductive Choice
Women around the world hope for the future-for better lives for themselves, education and prosperity for their children, and security for their families. A broad array of social and economic changes is necessary to overcome the poverty, lack of education, and limited control over their own lives that often keep women's hopes from coming time. But women can take an important step forward when they make their own reproductive choices-about marriage, sex, childbearing, and contraception. (WOMEN'S STATUS, CHOICE, REPRODUCTION)
1994 - SERIE J (FAMILY PLANNING PROGRAMMES), NUMBER 40
Family Planning Lessons and Challenges. Making Programs Work
Over the past 30 years, family planning programs have helped millions of people to have the smaller families that they want. As programs have learned how to meet people's needs, contraceptive use has spread rapidly. (FAMILY PLANNING PROGRAMMES, PROGRAMME EVALUATION, CONTRACEPTIVE PREVALENCE)
Back to home page